128 related articles for article (PubMed ID: 1345741)
21. IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier.
Niemelä J; Ifergan I; Yegutkin GG; Jalkanen S; Prat A; Airas L
Eur J Immunol; 2008 Oct; 38(10):2718-26. PubMed ID: 18825744
[TBL] [Abstract][Full Text] [Related]
22. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
Barkhof F; van Walderveen M
Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
[TBL] [Abstract][Full Text] [Related]
23. [The pathogenesis of multiple sclerosis].
Kesselring J
Schweiz Med Wochenschr; 1990 Jul; 120(30):1083-90. PubMed ID: 2203139
[TBL] [Abstract][Full Text] [Related]
24. Blood-brain barrier imaging and therapeutic potentials.
Rebeles F; Fink J; Anzai Y; Maravilla KR
Top Magn Reson Imaging; 2006 Apr; 17(2):107-16. PubMed ID: 17198226
[TBL] [Abstract][Full Text] [Related]
25. Brain-immune connection: immuno-regulatory properties of CNS-resident cells.
Becher B; Prat A; Antel JP
Glia; 2000 Feb; 29(4):293-304. PubMed ID: 10652440
[TBL] [Abstract][Full Text] [Related]
26. The impact of interferon-beta treatment on the blood-brain barrier.
Kraus J; Oschmann P
Drug Discov Today; 2006 Aug; 11(15-16):755-62. PubMed ID: 16846804
[TBL] [Abstract][Full Text] [Related]
27. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis.
Vos CM; Geurts JJ; Montagne L; van Haastert ES; Bö L; van der Valk P; Barkhof F; de Vries HE
Neurobiol Dis; 2005 Dec; 20(3):953-60. PubMed ID: 16039866
[TBL] [Abstract][Full Text] [Related]
28. Blood-brain barrier disruption in multiple sclerosis.
Minagar A; Alexander JS
Mult Scler; 2003 Dec; 9(6):540-9. PubMed ID: 14664465
[TBL] [Abstract][Full Text] [Related]
29. A dynamic view of the blood-brain barrier in active multiple sclerosis lesions.
Lassmann H
Ann Neurol; 2011 Jul; 70(1):1-2. PubMed ID: 21710628
[No Abstract] [Full Text] [Related]
30. [Implication of the blood-brain barrier in neurological diseases: part II].
Weiss N; Miller F; Cazaubon S; Couraud PO
Rev Neurol (Paris); 2009 Dec; 165(12):1010-22. PubMed ID: 19487004
[TBL] [Abstract][Full Text] [Related]
31. Multiple sclerosis as a vascular disease.
Minagar A; Jy W; Jimenez JJ; Alexander JS
Neurol Res; 2006 Apr; 28(3):230-5. PubMed ID: 16687046
[TBL] [Abstract][Full Text] [Related]
32. The blood-brain barrier in multiple sclerosis: microRNAs as key regulators.
Kamphuis WW; Derada Troletti C; Reijerkerk A; Romero IA; de Vries HE
CNS Neurol Disord Drug Targets; 2015; 14(2):157-67. PubMed ID: 25613507
[TBL] [Abstract][Full Text] [Related]
33. [Hyperhomocysteinemia and endothelial dysfunction in patients with cerebral vascular and autoimmune diseases].
Dubchenko EA; Ivanov AV; Boiko AN; Spirina NN; Gusev EI; Kubatiev AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(11):133-138. PubMed ID: 31851185
[TBL] [Abstract][Full Text] [Related]
34. Vascular pathology in multiple sclerosis: reframing pathogenesis around the blood-brain barrier.
Spencer JI; Bell JS; DeLuca GC
J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):42-52. PubMed ID: 28860328
[TBL] [Abstract][Full Text] [Related]
35. [Multiple sclerosis and endothelial dysfunction (a review)].
Spirina NN; Spirin NN; Fadeeva OA; Shipova EG; Boĭko AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(10 Pt 2):32-42. PubMed ID: 24416810
[TBL] [Abstract][Full Text] [Related]
36. Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis.
Claudio L; Raine CS; Brosnan CF
Acta Neuropathol; 1995; 90(3):228-38. PubMed ID: 8525795
[TBL] [Abstract][Full Text] [Related]
37. Increased adhesion of CD4+ and CD14+ mononuclear cells to cultured multiple sclerosis brain endothelial cells.
Dufour A; Corsini E; Giombini S; Nespolo A; Milanese C; Salmaggi A
J Neurol; 1996 Sep; 243(9):666-7. PubMed ID: 8892072
[No Abstract] [Full Text] [Related]
38. Blood brain barrier compromise with endothelial inflammation may lead to autoimmune loss of myelin during multiple sclerosis.
Simka M
Curr Neurovasc Res; 2009 May; 6(2):132-9. PubMed ID: 19442163
[TBL] [Abstract][Full Text] [Related]
39. Plaques, T cells and beyond: report on an international meeting on the immunological basis of multiple sclerosis held at the University of Chieti, Italy.
Muraro PA; Martin R; Lassmann H; Gambi D
J Neuroimmunol; 1999 May; 96(2):251-4. PubMed ID: 10337925
[No Abstract] [Full Text] [Related]
40. Search for autoantibodies to endothelial and smooth muscle cells in patients with multiple sclerosis.
Tsukada N; Behan WM; Behan PO
Acta Neuropathol; 1985; 66(2):134-9. PubMed ID: 3874512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
